As the jumbotron showed Takeda’s logo and Tom Petty’s “Free Fallin’” blared out over the PA, 100 toy zebras began floating down toward the crowd. Attendees eagerly plucked the striped ...

BioMarin Pharmaceutical logo (PRNewsfoto/BioMarin Pharmaceutical ... which was acquired by Takeda in 2009, and before that held leadership positions at NeoPharm Inc. and Abbott (now AbbVie).

–Dr. von Moltke brings over 30 years of deep drug development experience and a proven track record of clinical and regulatory success at both large and emerging global biopharmaceutical companies– ...

Harmony Biosciences (HRMY) announced the appointment of Adam Zaeske as executive VP and chief commercial officer, effective March 31. The ...

Takeda’s revamped R&D strategy means the drugmaker’s oncology leaders are prioritizing work in tumors across thoracic, gastrointestinal (GI) and hematology, while pushing the Japanese company ...

Assetmark Inc. grew its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) by 6.4% in the fourth quarter, according to its most recent filing with the SEC.

SANYA, China (AP) — Rio Takeda shot a blistering 8-under 64 on Sunday to win the LPGA's Blue Bay tournament by six shots ahead of Minjee Lee of Australia, the second LPGA title for the young ...

SANYA, China — Rio Takeda of Japan shot a 3-under 69 on Saturday to hold a two-shot lead after three rounds of the LPGA’s Blue Bay tournament on China’s southern island of Hainan.

− All four key secondary endpoints were met, including EU primary endpoint and patient-reported outcomes NEWARK, Calif. & OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Protagonist ...